Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Steven Chuan-Hao Kao"'
Autor:
Michaela B Kirschner, J James B Edelman, Steven Chuan-Hao Kao, Michael P Vallely, Nico eVan Zandwijk, Glen eReid
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
Cell-free microRNAs in plasma and serum have become a promising source of biomarkers for various diseases. Despite rapid progress in this field, there remains a lack of consensus regarding optimal quantification methods, reference genes and quality c
Externí odkaz:
https://doaj.org/article/3aa61044da5d43e3b97d433e2bbbd582
Autor:
Udit Nindra, Samuel Xavier Stevens, Adel Shahnam, Abhijit Pal, Tamiem Adam, Po Yee Yip, Jenny HJ Lee, Michael J. Boyer, Adnan Nagrial, Steven Chuan-Hao Kao, Victoria Jane Bray
Publikováno v:
Journal of Clinical Oncology. 40:e18810-e18810
e18810 Background: The PACIFIC trial established concurrent chemoradiation followed by one year of consolidation durvalumab as the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). However, the data to support the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::772499fc14aae3aef6ae711b7f00258b
https://doi.org/10.1200/jco.2022.40.16_suppl.e18810
https://doi.org/10.1200/jco.2022.40.16_suppl.e18810
Autor:
Udit Nindra, Adel Shahnam, Samuel Xavier Stevens, Abhijit Pal, Po Yee Yip, Tamiem Adam, Jenny HJ Lee, Michael J. Boyer, Adnan Nagrial, Steven Chuan-Hao Kao, Victoria Jane Bray
Publikováno v:
Journal of Clinical Oncology. 40:e18773-e18773
e18773 Background: The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) has been of prognostic interest in lung cancer. Sustained NLR and PLR after initial chemoradiotherapy (CRT) has been shown to correlate with worse prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a86c840e98abdec4a79c619559981566
https://doi.org/10.1200/jco.2022.40.16_suppl.e18773
https://doi.org/10.1200/jco.2022.40.16_suppl.e18773
Autor:
Samuel Xavier Stevens, Udit Nindra, Adel Shahnam, Victoria Jane Bray, Po Yee Yip, Tamiem Adam, Jenny HJ Lee, Michael J. Boyer, Adnan Nagrial, Steven Chuan-Hao Kao
Publikováno v:
Journal of Clinical Oncology. 40:e18809-e18809
e18809 Background: Consolidation treatment with durvalumab following CRT is now standard of care for pts with unresectable stage III NSCLC. In PACIFIC, durvalumab was administered within 42 days of completing CRT. There has also been recent interest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1db12d6ba4990a00e81192275e4e62d
https://doi.org/10.1200/jco.2022.40.16_suppl.e18809
https://doi.org/10.1200/jco.2022.40.16_suppl.e18809
Autor:
Steven Chuan-Hao Kao1, Mei Ling Yap2, Berry, Martin2, Santos, Leonardo3, Lin, Michael4, Goldrick, Amanda1 amanda.goldrick@sswahs.nsw.gov.au
Publikováno v:
Asia Pacific Journal of Oncology & Hematology. 2009, Vol. 1 Issue 3, p91-94. 4p. 2 Color Photographs.
Autor:
Steven Chuan-Hao, Kao, Nico, van Zandwijk, Stephen, Clarke, Janette, Vardy, Sumit, Lumba, Annette, Tognela, Weng, Ng
Publikováno v:
Asia-Pacific journal of clinical oncology. 11(1)
Chemotherapy with cisplatin and pemetrexed has been shown to provide a survival benefit and improvement in quality of life in patients with malignant pleural mesothelioma (MPM). The reported chemotherapy utilization rates range from 18% to 61%. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1bc19f4ce10f9204aa3cd12d2840633
https://pubmed.ncbi.nlm.nih.gov/25382807
https://pubmed.ncbi.nlm.nih.gov/25382807